These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8655889)

  • 21. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE
    N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
    Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
    Taylor DR; Town GI; Herbison GP; Boothman-Burrell D; Flannery EM; Hancox B; Harré E; Laubscher K; Linscott V; Ramsay CM; Richards G
    Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmeterol tachyphylaxis in steroid treated asthmatic subjects.
    Booth H; Bish R; Walters J; Whitehead F; Walters EH
    Thorax; 1996 Nov; 51(11):1100-4. PubMed ID: 8958892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.
    Nowak D; Jörres R; Rabe KF; Lüthke M; Wiessmann J; Magnussen H
    Eur J Clin Pharmacol; 1992; 43(6):591-5. PubMed ID: 1493839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses.
    de Benedictis FM; Tuteri G; Pazzelli P; Niccoli A; Mezzetti D; Vaccaro R
    Eur Respir J; 1996 Oct; 9(10):2099-103. PubMed ID: 8902473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.
    Castle W; Fuller R; Hall J; Palmer J
    BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
    BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
    Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
    Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.